E2F3 served as a promoter regulator in colon cancer, aggravating tumorigenesis and stemness in colon cancer progression through the STAT3 pathway.<h4>Conclusion</h4>E2F3 may be a useful biomarker for anticancer treatment in colon cancer. This evidence concerns the gene E2F3 and malignant colon neoplasm.